Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD40 agon
Welcome,
Profile
Billing
Logout
30 Companies
29 Products
29 Products
44 Diseases
49 Trials
1042 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
sotigalimab
(PYX-107) / Pyxis Oncology
CDX-1140
/ Celldex
CP-870893
/ Pfizer
selicrelumab
(RG7876) / Roche
ISF35
/ Memgen
2141-V11
/ Memorial Sloan-Kettering Cancer Center, Rockefeller University
mitazalimab
(ADC-1013) / Alligator Biosci
GEN1042
/ Genmab, BioNTech
GM.CD40L cell vaccine
/ AbelZeta Pharma, H. Lee Moffitt Cancer Center and Research Institute
TriMix-DC
(ex-vivo autologous dendritic cells vaccine) / eTheRNA immunotherapies
YH003
/ Biocytogen
BNT113
/ BioNTech
NG-350A
/ Akamis Bio
SL-172154
/ Shattuck
dalnicastobart
(LVGN7409) / Lyvgen
giloralimab
(ABBV-927) / AbbVie
BSI-038
/ Biosion
cifurtilimab
(SEA-CD40) / Pfizer
ABBV-428
/ AbbVie
Chi Lob 7/4
/ Cancer Research UK, BioNTech
MEDI5083
/ AstraZeneca
MP0317
/ Molecular Partners
RG6189
/ Roche
TQB2916
/ Sino Biopharm
YH008
/ Biocytogen
inezetamab
(AMG994) / Amgen
